Showing results (71-80 of 127) with videos related to
Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Feasibility and correlates of arsenic trioxide combined with ascorbic acid-mediated depletion of intracellular glutathione for the treatment of relapsed/refractory multiple myelomaNizar J Bahlis, Jennifer McCafferty-Grad, Ileana Jordan-McMurry, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 1, 2011
CD28 expressed on malignant plasma cells induces a prosurvival and immunosuppressive microenvironmentJayakumar R Nair, Louise M Carlson, Chandana Koorella, et al.Blood|October 31, 2002
Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-kappa BSubrata K Ghosh, Charles Wood, Lawrence H Boise, et al.Cancer|October 18, 2018
Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agentsRoberto Mina, Nisha S Joseph, Jonathan L Kaufman, et al.Molecular Cancer|September 28, 2011
A MCP1 fusokine with CCR2-specific tumoricidal activityMoutih Rafei, Jiusheng Deng, Marie-Noëlle Boivin, et al.Blood|September 20, 2023
Integrated epigenetic and transcriptional single-cell analysis of t(11;14) multiple myeloma and its BCL2 dependencyNoémie Leblay, Sungwoo Ahn, Rémi Tilmont, et al.Cancer Informatics|October 8, 2014
Integrated analysis of whole-genome paired-end and mate-pair sequencing data for identifying genomic structural variations in multiple myelomaRendong Yang, Li Chen, Scott Newman, et al.Blood|February 22, 2007
CD28-mediated regulation of multiple myeloma cell proliferation and survivalNizar J Bahlis, Anne M King, Despina Kolonias, et al.Anticancer Research|July 5, 2018
Efficacy and Safety of Sorafenib in a Racially Diverse Patient Population with Advanced Hepatocellular CarcinomaTimothy M Schmidt, L I Liu, Ivy E Abraham, et al.British Journal of Haematology|February 25, 2015
Ricolinostat (ACY-1215) induced inhibition of aggresome formation accelerates carfilzomib-induced multiple myeloma cell deathYuko Mishima, Loredana Santo, Homare Eda, et al.Pageof 13